A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CII

Search Conditions:
Search Keyword : CII
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: CII
Appearance Frequency: 1190 time(s)
Long forms: 262

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
II collagen
(454 times)
Allergy and Immunology
(172 times)
CIA (223 times)
RA (127 times)
IL (20 times)
1986 [Induction of arthritis in mice by injection of homologous type II collagen].
collagen type II
(116 times)
Allergy and Immunology
(45 times)
RA (42 times)
CIA (37 times)
IL (11 times)
1986 Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.
complex II
(48 times)
Biochemistry
(8 times)
CI (18 times)
ROS (13 times)
SDH (6 times)
2007 Mitochondrial mechanism of neuroprotection by CART.
collagen II
(45 times)
Allergy and Immunology
(16 times)
CIA (25 times)
RA (17 times)
TCR (5 times)
1989 Oestrogen-mediated suppression of collagen-induced arthritis in rats. Studies on the role of the thymus and of peripheral CD8+ T lymphocytes.
chicken type II collagen
(34 times)
Allergy and Immunology
(15 times)
CIA (14 times)
RA (10 times)
WT (4 times)
1987 Attenuation of collagen arthritis and modulation of delayed-type hypersensitivity by type II collagen reactive T-cell lines.
Childhood Immunization Initiative
(25 times)
Public Health
(24 times)
Hib (11 times)
NIS (8 times)
MMR (5 times)
1994 Vaccination coverage of 2-year-old children--United States, third quarter, 1993.
cognitive impairment index
(19 times)
Neurology
(10 times)
SLE (5 times)
MS (3 times)
RRMS (3 times)
1999 Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease.
continuous insulin infusion
(15 times)
Endocrinology
(4 times)
ICU (4 times)
BG (3 times)
DKA (3 times)
1982 Continuous insulin infusion in hyperglycemic, very low birth weight infants.
continuous intravenous infusion
(15 times)
Endocrinology
(3 times)
ICU (6 times)
PCA (2 times)
SCB (2 times)
2001 A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl.
10  anti-collagen type II
(14 times)
Allergy and Immunology
(9 times)
CIA (7 times)
RA (6 times)
TNF-alpha (2 times)
1994 Accelerated onset of collagen-induced arthritis by remote inflammation.
11  class II
(11 times)
Transplantation
(2 times)
CI (8 times)
sHSPs (2 times)
WT (2 times)
2003 Purification and characterization of class-I and class-II fructose-1,6-bisphosphate aldolases from the cyanobacterium Synechocystis sp. PCC 6803.
12  type-II collagen
(11 times)
Allergy and Immunology
(7 times)
CIA (4 times)
RA (3 times)
AC (1 time)
1993 Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis.
13  critical illness insurance
(10 times)
Health Services
(4 times)
OOP (5 times)
CHE (4 times)
AG (1 time)
2011 Equitable access to healthcare services and income replacement for cancer: is critical illness insurance a help or a hindrance?
14  CIA was induced by immunization with type II collagen
(9 times)
Pharmacology
(3 times)
CIA (9 times)
IL (2 times)
IL-1 (2 times)
1999 Enhancement of collagen-induced arthritis in mice by diesel exhaust particles.
15  correlation intensity index
(9 times)
Toxicology
(5 times)
IIC (6 times)
QSARs (2 times)
DCW (1 time)
2020 Correlation intensity index: Building up models for mutagenicity of silver nanoparticles.
16  Contrast Improvement Index
(8 times)
Medical Informatics
(6 times)
CLAHE (2 times)
PSNR (2 times)
AG (1 time)
2012 Comparing the performance of image enhancement methods to detect microcalcification clusters in digital mammography.
17  cultural importance index
(8 times)
Social Sciences
(6 times)
FL (6 times)
IAR (6 times)
RFC (5 times)
2011 Documentation and quantitative analysis of the local knowledge on medicinal plants among traditional Siddha healers in Virudhunagar district of Tamil Nadu, India.
18  Chiari type II malformation
(7 times)
Neurology
(7 times)
MRI (1 time)
SP (1 time)
VOR (1 time)
2005 Saccades in children with spina bifida and Chiari type II malformation.
19  chronic inflammatory infiltrate
(7 times)
Urologic Diseases
(3 times)
PCa (6 times)
PSA (4 times)
PV (3 times)
1997 Cytotoxicity of Ketac Silver cement.
20  chicken collagen type II
(6 times)
Rheumatology
(2 times)
CIA (5 times)
RA (3 times)
CAIA (1 time)
2008 Prophylactic but not therapeutic activity of a monoclonal antibody that neutralizes the binding of VEGF-B to VEGFR-1 in a murine collagen-induced arthritis model.
21  checkpoint inhibitor immunotherapy
(5 times)
Neoplasms
(3 times)
cfmiR (2 times)
miRs (2 times)
NGS (2 times)
2019 Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.
22  chronic intestinal ischemia
(5 times)
General Surgery
(3 times)
SMA (3 times)
CA (2 times)
SBF (2 times)
2002 Endovascular treatment as first choice in chronic intestinal ischemia.
23  clinically important improvement
(5 times)
Rheumatology
(3 times)
axSpA (2 times)
MI (2 times)
altASDAS (1 time)
2020 The impact of multijoint symptoms on patient-reported disability following surgery for lumbar spine osteoarthritis.
24  anti-collagen II
(4 times)
Pharmacology
(2 times)
CIA (3 times)
RA (3 times)
CNBr (1 time)
1994 Meniere's disease: role of antibodies against basement membrane antigens.
25  cell responses to type II collagen
(4 times)
Rheumatology
(3 times)
RA (4 times)
CIA (2 times)
anti-VEGF (1 time)
1997 T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls.
26  chromosome II
(4 times)
Genetics
(1 time)
C-I (2 times)
MSHA (1 time)
VPI-2 (1 time)
2006 Genome analyses of three strains of Rhodobacter sphaeroides: evidence of rapid evolution of chromosome II.
27  Composite Index of Impairments
(4 times)
Neurology
(3 times)
--- 1993 Epilepsy treatment in The Netherlands. Comparison of two medical centres.
28  COX-2 gene were immunized with type II collagen
(4 times)
Allergy and Immunology
(3 times)
CIA (4 times)
LPS (2 times)
COX-1 (1 time)
2001 The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis.
29  Cancer Informatics Infrastructure
(3 times)
Medical Informatics
(2 times)
CDEs (1 time)
NCI (1 time)
1999 Role of clinical trials informatics in the NCI's cancer informatics infrastructure.
30  cartilage protein, collagen type II
(3 times)
Biochemistry
(1 time)
CIA (2 times)
RA (2 times)
CTRL (1 time)
2009 Pathogenic antibody recognition of cartilage.
31  cartilage type II collagen
(3 times)
Rheumatology
(1 time)
OA (2 times)
ACAID (1 time)
APCs (1 time)
2003 Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
32  cell determinant of type II collagen
(3 times)
Allergy and Immunology
(2 times)
CIA (1 time)
rCII (1 time)
1994 Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice.
33  cell recognition of the type II collagen
(3 times)
Allergy and Immunology
(3 times)
CIA (1 time)
1992 Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection.
34  cellular type II collagen
(3 times)
Rheumatology
(2 times)
RA (2 times)
TNF-alpha (2 times)
CIA (1 time)
2001 Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain.
35  chilling injury index
(3 times)
Plant Physiological Phenomena
(2 times)
GWAS (1 time)
PAL (1 time)
POD (1 time)
2001 Effect of temperature on enzymatic and physiological factors related to chilling injury in carambola fruit (Averrhoa carambola L.).
36  class II collagenase
(3 times)
Transplantation
(3 times)
CI (3 times)
CDA (1 time)
SDS-PAGE (1 time)
2007 Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme.
37  Colon Inflammatory Index
(3 times)
Neoplasms
(2 times)
LDH (2 times)
NLR (2 times)
OS (2 times)
2019 Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer(ITACa) study.
38  component II
(3 times)
Biochemistry
(2 times)
CI (3 times)
ESR (1 time)
IEF (1 time)
1984 Bohr effect, electron spin resonance spectroscopy and subunit dissociation of the hemoglobin components from the turtle Phrynops hilarii.
39  computational integral imaging
(3 times)
Ophthalmology
(3 times)
EIA (1 time)
IBP (1 time)
SR (1 time)
2007 Improved analysis on the signal property of computational integral imaging system.
40  continuous intravenous insulin infusions
(3 times)
Endocrinology
(3 times)
CABG (2 times)
BG (1 time)
CBG (1 time)
2006 Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project.
41  Critical Incident Inventory
(3 times)
Occupational Health
(2 times)
--- 2020 Prevalence of exposure to critical incidents in firefighters across Canada.
42  CAARS Infrequency Index
(2 times)
Psychology
(1 time)
ADHD (2 times)
CAARS (2 times)
INC (1 time)
2017 Utility of the Conners' Adult ADHD Rating Scale validity scales in identifying simulated attention-deficit hyperactivity disorder and random responding.
43  Canine-Incisor Index
(2 times)
Dentistry
(1 time)
c-CII (1 time)
CCI (1 time)
2000 Reliability of a method for the localization of displaced maxillary canines using a single panoramic radiograph.
44  capable of altering the immune response to type II collagen
(2 times)
Rheumatology
(1 time)
CIA (1 time)
IL-4 (1 time)
2002 Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
45  cartilage component type II collagen
(2 times)
Pharmacology
(1 time)
LPS (2 times)
CIA (1 time)
IgG (1 time)
2000 The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice.
46  cartilage-specific type II collagen
(2 times)
Rheumatology
(1 time)
MMPs (1 time)
OA (1 time)
RA (1 time)
1998 Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
47  caused by type II collagen
(2 times)
Allergy and Immunology
(2 times)
CFA (2 times)
iNOS (2 times)
MIP (2 times)
2006 Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
48  cell injury index
(2 times)
Pulmonary Medicine
(1 time)
GPx (2 times)
AM (1 time)
BSO (1 time)
1992 In vitro effects of hyperoxia on alveolar type II pneumocytes: inhibition of glutathione synthesis increases hyperoxic cell injury.
49  cells specific for type II collagen
(2 times)
Rheumatology
(1 time)
CIA (1 time)
RP (1 time)
2002 Identification of type II collagen peptide 261-273-specific T cell clones in a patient with relapsing polychondritis.
50  cellulose II
(2 times)
Molecular Biology
(1 time)
CI (2 times)
CFs (1 time)
CNC (1 time)
2018 Cellulose I and II nanocrystals produced by sulfuric acid hydrolysis of Tetra pak cellulose I.
51  central terminals of type II synaptic glomeruli
(2 times)
Neurology
(1 time)
FRAP (2 times)
TI (1 time)
1989 Postnatal maturation of primary afferent terminations in the substantia gelatinosa of the rat spinal cord. An electron microscopic study.
52  cerebral ischemia injury
(2 times)
Molecular Biology
(1 time)
ER (1 time)
HUVECs (1 time)
I/R (1 time)
2019 Downregulation of microRNA‑451 improves cell migration, invasion and tube formation in hypoxia‑treated HUVECs by targeting MIF.
53  chronic intestinal inflammation
(2 times)
Rheumatology
(1 time)
AF (1 time)
AU (1 time)
CD (1 time)
1995 Bowel inflammation in anterior uveitis and spondyloarthropathy.
54  CIA, type II collagen
(2 times)
Allergy and Immunology
(2 times)
CIA (2 times)
CFA (1 time)
IFA (1 time)
2002 IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis.
55  citrullinated type II collagen
(2 times)
Allergy and Immunology
(2 times)
ACPAs (1 time)
LC (1 time)
NC1 (1 time)
2010 Antibodies to citrullinated proteins: molecular interactions and arthritogenicity.
56  clinical score, paw thickness, and type II collagen
(2 times)
Rheumatology
(2 times)
CIA (2 times)
CTLA-4 (1 time)
CTLA4-Ig (1 time)
2000 Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis.
57  Cluster II
(2 times)
Allergy and Immunology
(1 time)
CI (1 time)
CIN (1 time)
HSS1 and 2 (1 time)
2002 Variegated expression of CD8 alpha resulting from in situ deletion of regulatory sequences.
58  complex I and II
(2 times)
Biological Science Disciplines
(1 time)
CHD (1 time)
CI (1 time)
ETS (1 time)
2013 Substrate-specific impairment of mitochondrial respiration in permeabilized fibers from patients with coronary heart disease versus valvular disease.
59  concentrations and type II collagen
(2 times)
Rheumatology
(1 time)
RA (2 times)
AA (1 time)
CIA (1 time)
2005 Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis.
60  Concept II
(2 times)
Sports Medicine
(1 time)
WB (1 time)
1995 An evaluation of instrumented tank rowing for objective assessment of rowing performance.
61  confidence intervals
(2 times)
General Surgery
(1 time)
BUN (1 time)
eRVF (1 time)
HRT (1 time)
1998 Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow.
62  content of anti-type II collagen
(2 times)
Therapeutics
(1 time)
CCII (1 time)
CIA (1 time)
FcRbeta (1 time)
2012 Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model.
63  Continuous Innovation Indicators
(2 times)
Pharmaceutical Preparations
(1 time)
FDA (1 time)
OS (1 time)
2017 Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII).
64  contribution of type II collagen
(2 times)
Rheumatology
(2 times)
RA (2 times)
CIA (1 time)
CTGF (1 time)
1992 Interactions of synovial fluid immunoglobulins with chondrocytes.
65  cumulative intervention intensity
(2 times)
Rehabilitation
(2 times)
FITT (1 time)
MDAF (1 time)
VERSE (1 time)
2020 An exploration of aphasia therapy dosage in the first six months of stroke recovery.
66  2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole
(1 time)
Pulmonary Medicine
(1 time)
ECs (1 time)
PTX (1 time)
S1P (1 time)
2011 Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways.
67  alpha-chain of human type II collagen
(1 time)
Allergy and Immunology
(1 time)
--- 1996 Characterization of the antigenic structure of human type II collagen.
68  c mice by been subcutaneously injected type II bovine collagen
(1 time)
Pharmacology
(1 time)
ARCF (1 time)
EE (1 time)
IL-1beta (1 time)
2010 Extracts of Arisaema rhizomatum C.E.C. Fischer attenuate inflammatory response on collagen-induced arthritis in BALB/c mice.
69  c mice by two intradermal injections of type II collagen
(1 time)
Cells
(1 time)
ANA (1 time)
CIA (1 time)
COMP (1 time)
2019 Combination Therapy of Mesenchymal Stromal Cells and Interleukin-4 Attenuates Rheumatoid Arthritis in a Collagen-Induced Murine Model.
70  C-terminal domain
(1 time)
Science
(1 time)
--- 2018 Molecular dynamics simulations of nucleotide release from the circadian clock protein KaiC reveal atomic-resolution functional insights.
71  Calcipex II
(1 time)
Dentistry
(1 time)
CP (1 time)
CZ (1 time)
FT-Raman (1 time)
2017 Molecular and morphological surface analysis: effect of filling pastes and cleaning agents on root dentin.
72  calcitonin treatment influences the increases in type II collagen
(1 time)
Rheumatology
(1 time)
--- 2007 The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model.
73  can be suppressed by intravenous injection of native type II
(1 time)
Allergy and Immunology
(1 time)
CB (1 time)
1989 Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis.
74  can present DR4-restricted type II collagen
(1 time)
Rheumatology
(1 time)
CIA (1 time)
RA (1 time)
2006 New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis.
75  can react identically with a single epitope on one antigen
(1 time)
Allergy and Immunology
(1 time)
mAb (1 time)
2004 Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry.
76  can recognize peptide antigens derived from type-II collagen
(1 time)
Biochemistry
(1 time)
CIA (1 time)
2016 Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules.
77  can render oral tolerance to type II collagen
(1 time)
Rheumatology
(1 time)
CIA (1 time)
TGF-beta (1 time)
1999 Modulation by cytokines of induction of oral tolerance to type II collagen.
78  can suppress the development and progression of type II collagen
(1 time)
Medicine
(1 time)
HFLS (1 time)
PKD1 (1 time)
TLR (1 time)
2019 Ameliorating effects of Go6976, a pharmacological agent that inhibits protein kinase D, on collagen-induced arthritis.
79  candidate autoantigen type II collagen
(1 time)
Allergy and Immunology
(1 time)
CIA (1 time)
DR4 (1 time)
RA (1 time)
2002 The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
80  capable of producing antibodies reactive to type II collagen
(1 time)
Rheumatology
(1 time)
Ig (1 time)
PB (1 time)
RA (1 time)
2001 Anti-Human type II collagen CD19+ B cells are present in patients with rheumatoid arthritis and healthy individuals.
81  carbon intensity indicator
(1 time)
Environmental Health
(1 time)
EEXI (1 time)
IMO (1 time)
TEU (1 time)
2023 Environmental economic analysis of speed reduction measure onboard container ships.
82  carbon ion implantation
(1 time)
Nanotechnology
(1 time)
CoCrMo (1 time)
MoM (1 time)
2017 Effect of carbon ion implantation on the tribology of metal-on-metal bearings for artificial joints.
83  carbon ion irradiation
(1 time)
Neoplasms
(1 time)
DNP (1 time)
GLUT1 (1 time)
HKII (1 time)
2023 Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines.
84  carcinoma were injected with Type II collagen
(1 time)
Neoplasms
(1 time)
AA (1 time)
GF-II (1 time)
IL-17 (1 time)
2011 Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer.
85  carrier-induced interlayer
(1 time)
Biomedical Engineering
(1 time)
a-IGZO TFTs (1 time)
VGO (1 time)
2021 Vertically Graded Oxygen Deficiency for Improving Electrical Characteristics and Stability of Indium Gallium Zinc Oxide Thin-Film Transistors.
86  cartilage damage; furthermore, the production of type II collagen
(1 time)
Rheumatology
(1 time)
CAIA (1 time)
CIA (1 time)
FcgammaRIIb (1 time)
2010 The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody.
87  cartilage degradation through type II collagen
(1 time)
Rheumatology
(1 time)
HNE (1 time)
MMP-13 (1 time)
OA (1 time)
2005 Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation.
88  cartilage derived molecule type II collagen
(1 time)
Rheumatology
(1 time)
RA (1 time)
SLE (1 time)
1995 Local versus systemic immunoreactivity to collagen and the collage-like region of C1q in rheumatoid arthritis and SLE.
89  cartilage destruction and significantly reduced pathogenic anti-type II collagen
(1 time)
Allergy and Immunology
(1 time)
BiP (1 time)
ELISA (1 time)
IFN (1 time)
2014 Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis.
90  cartilage include type II collagen
(1 time)
Allergy and Immunology
(1 time)
DC (1 time)
2002 Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages.
91  cartilage matrix macromolecules including type II collagen
(1 time)
Orthopedics
(1 time)
BMI (1 time)
CE (1 time)
HNS (1 time)
2006 Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies.
92  cartilage proteins, proteoglycans, and type II collagen
(1 time)
Biochemistry
(1 time)
EA (1 time)
MMPs (1 time)
PA (1 time)
2013 Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo.
93  Cartilage was analyzed for type II collagen
(1 time)
Rheumatology
(1 time)
CPII (1 time)
2006 Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface.
94  cartilage-specific proteins type II collagen
(1 time)
Rheumatology
(1 time)
CXI (1 time)
MHC (1 time)
PIA (1 time)
2012 Class II major histocompatibility complex-associated response to type XI collagen regulates the development of chronic arthritis in rats.
95  casei administration reduced type II collagen
(1 time)
Allergy and Immunology
(1 time)
CIA (1 time)
L. casei (1 time)
RA (1 time)
2008 Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions.
96  casei alone or together with type II collagen
(1 time)
Biochemistry
(1 time)
GLN (1 time)
IFN-gamma (1 time)
IL-1beta (1 time)
2010 Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis.
97  casein II
(1 time)
Physiology
(1 time)
CI (1 time)
1981 Absorption of amino acids in different parts of the small intestine in growing pigs. III. Absorption of constituents of protein hydrolysates.
98  cases in the insular portion of the ipsilateral claustrum
(1 time)
Neurology
(1 time)
FB (1 time)
NY (1 time)
1983 Claustroneocortical projections studied in the cat by means of multiple retrograde fluorescent tracing.
99  casiopeina II (Cu(4,7-dimethyl-1,10-phenanthroline)(glycine)NO3)
(1 time)
Toxicology
(1 time)
Hb (1 time)
PCV (1 time)
RBC (1 time)
2003 Hematotoxicity response in rats by the novel copper-based anticancer agent: casiopeina II.
100  category II
(1 time)
Diabetes Mellitus
(1 time)
CI (1 time)
CIII (1 time)
CKD (1 time)
2014 Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes.